Efsun Gonca Uğur Chousein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Efsun Gonca Uğur Chousein has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Demet Turan
Department of Pulmonology, Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, University of Health Sciences, Istanbul, Türkiye
16 shared publications - Mehmet Akif Özgül
Basaksehir Cam and Sakura City Hospital, Department of Pulmonology, Istanbul, Turkey
15 shared publications - Erdoğan Çetinkaya
Department of Chest Disease, Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, University of Health Sciences, Istanbul, Turkey
12 shared publications - Elif Tanrıverdi
Department of Pulmonology, Yedikule Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey
7 shared publications - Binnaz Zeynep Yıldırım
Department of Chest Diseases, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkiye
6 shared publications - Halit Çınarka
Department of Chest Diseases, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkiye
6 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (46) , e51593
Changes in quality of life, sleep quality, and anxiety following tracheobronchial stenting in patients with central airway obstruction: A retrospective observational study
Central airway obstruction (CAO) severely impairs respiratory function and psychosocial well-being. This study evaluated the impact of tracheobronchial stenting on quality of life, sleep quality, and anxiety levels in patients with CAO. This retrospective observational study included 106 patients (63.2% male) who underwent tracheobronchial stenting between January and September 2024. Patients were assessed 1 day before and 1 month after the procedure using the Short Form-36, Beck Anxiety Inventory (BAI), and Pittsburgh Sleep Quality Index (PSQI). Significant improvements were observed in all Short Form-36 subscales ( P < .001), except for mental health ( P = .094). The largest improvement was observed in physical functioning, with median scores increasing from 22.5 to 80.0. Median BAI scores decreased from 38 to 22, and PSQI scores improved from 15 to 10 ( P < .001 for both). Effect size analysis demonstrated large improvements (Cohen dz = 1.110 for BAI and 1.555 for PSQI). Improvements were similar across malignant and benign (post-intubation tracheal stenosis) etiologies. Female patients demonstrated greater reductions in anxiety ( P = .005). Multivariate analysis identified age and educational level as independent predictors of anxiety change ( R 2 = 0.289, P < .001). Tracheobronchial stenting is associated with significant improvements in quality of life, sleep quality, and anxiety. These findings demonstrate that the clinical benefit of airway stenting extends beyond airway patency to include improvements in patient-centered outcomes, highlighting the importance of integrating psychosocial assessment into interventional pulmonology practice.
- 13 November 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (46) , e51593
Open AccessChanges in quality of life, sleep quality, and anxiety following tracheobronchial stenting in patients with central airway obstruction: A retrospective observational study
Central airway obstruction (CAO) severely impairs respiratory function and psychosocial well-being. This study evaluated the impact of tracheobronchial stenting on quality of life, sleep quality, and anxiety levels in patients with CAO. This retrospective observational study included 106 patients (63.2% male) who underwent tracheobronchial stenting between January and September 2024. Patients were assessed 1 day before and 1 month after the procedure using the Short Form-36, Beck Anxiety Inventory (BAI), and Pittsburgh Sleep Quality Index (PSQI). Significant improvements were observed in all Short Form-36 subscales ( P < .001), except for mental health ( P = .094). The largest improvement was observed in physical functioning, with median scores increasing from 22.5 to 80.0. Median BAI scores decreased from 38 to 22, and PSQI scores improved from 15 to 10 ( P < .001 for both). Effect size analysis demonstrated large improvements (Cohen dz = 1.110 for BAI and 1.555 for PSQI). Improvements were similar across malignant and benign (post-intubation tracheal stenosis) etiologies. Female patients demonstrated greater reductions in anxiety ( P = .005). Multivariate analysis identified age and educational level as independent predictors of anxiety change ( R 2 = 0.289, P < .001). Tracheobronchial stenting is associated with significant improvements in quality of life, sleep quality, and anxiety. These findings demonstrate that the clinical benefit of airway stenting extends beyond airway patency to include improvements in patient-centered outcomes, highlighting the importance of integrating psychosocial assessment into interventional pulmonology practice.
- 25 June 2026
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 74 (2) , 121-125
Treatment of severe tracheobronchopathia osteochondroplastica: Application of endobronchial argon plasma coagulation, presentation of three cases and literature review
Tracheobronchopathia osteochondroplastica (TBPO) is a rare condition characterized by the abnormal growth of cartilage within the trachea and main bronchi, leading to airway obstruction. The exact cause of TBPO is unknown, but it is thought to be associated with chronic inflammation of the airways and abnormal cartilage metabolism. Since there is not a standardization, the treatment of the condition depends on disease symptoms, infection status and the severity of the airway obstruction. Here, we aimed to present three cases of severe TBPO successfully managed in our interventional pulmonology unit applying argon plasma coagulation and mechanical debulking with rigid bronchoscopy, as well as the literature review.
- 25 June 2026
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 74 (2) , 121-125
Treatment of severe tracheobronchopathia osteochondroplastica: Application of endobronchial argon plasma coagulation, presentation of three cases and literature review
Tracheobronchopathia osteochondroplastica (TBPO) is a rare condition characterized by the abnormal growth of cartilage within the trachea and main bronchi, leading to airway obstruction. The exact cause of TBPO is unknown, but it is thought to be associated with chronic inflammation of the airways and abnormal cartilage metabolism. Since there is not a standardization, the treatment of the condition depends on disease symptoms, infection status and the severity of the airway obstruction. Here, we aimed to present three cases of severe TBPO successfully managed in our interventional pulmonology unit applying argon plasma coagulation and mechanical debulking with rigid bronchoscopy, as well as the literature review.
- Open Access
- 12 January 2026
- Published by LookUs Bilisim A.S. in Medical Records
- No. 1
The Role of Interventional Bronchoscopy in the Management of Haemoptysis
Aim: Haemoptysis is a clinical condition characterised by blood in the airways and is difficult to manage even for experienced clinicians. Bronchoscopy is a crucial tool in the treatment and evaluation of haemoptysis. However, we see that it is not used sufficiently in diagnosis and treatment. Within the scope of our research, we aimed to investigate the place and importance of bronchoscopy in haemoptysis through our bronchoscopy applications in patients we follow with the diagnosis of haemoptysis. Material and Method: The files and data of patients who were admitted to the Pulmonary Diseases Department and Intensive Care Unit with the diagnosis of haemoptysis or who were followed up as outpatients and underwent bronchoscopy were retrospectively reviewed. Results: Bronchoscopy findings were normal in 18% of patients, endobronchial lesions (EBL) in 18%, external compression in 1%, mucosal-submucosal infiltration, increased raying in 4%, narrowing of orifices in 2%, mucosal petechiae-vascularity increased in 2%, fragile mucosal hyperaemia-oedema in 12%, active haemorrhage in 5%, haemoptysis residues-coagulum in 37%, and purulent secretion in 1%. While no findings were observed in 19% of the patients during bronchoscopy and no procedure was performed, 55% received topical applications, 7% received only thermal applications, and 19% received both thermal and endobronchial treatments (EBT). Conclusion: We believe that our study will support the existing literature by revealing that bronchoscopy plays an important role in the diagnosis and treatment processes of patients with haemoptysis and that this method has the potential to increase its clinical contributions in the future.
- 12 January 2026
- Published by LookUs Bilisim A.S. in Medical Records
- No. 1
Open AccessThe Role of Interventional Bronchoscopy in the Management of Haemoptysis
Aim: Haemoptysis is a clinical condition characterised by blood in the airways and is difficult to manage even for experienced clinicians. Bronchoscopy is a crucial tool in the treatment and evaluation of haemoptysis. However, we see that it is not used sufficiently in diagnosis and treatment. Within the scope of our research, we aimed to investigate the place and importance of bronchoscopy in haemoptysis through our bronchoscopy applications in patients we follow with the diagnosis of haemoptysis. Material and Method: The files and data of patients who were admitted to the Pulmonary Diseases Department and Intensive Care Unit with the diagnosis of haemoptysis or who were followed up as outpatients and underwent bronchoscopy were retrospectively reviewed. Results: Bronchoscopy findings were normal in 18% of patients, endobronchial lesions (EBL) in 18%, external compression in 1%, mucosal-submucosal infiltration, increased raying in 4%, narrowing of orifices in 2%, mucosal petechiae-vascularity increased in 2%, fragile mucosal hyperaemia-oedema in 12%, active haemorrhage in 5%, haemoptysis residues-coagulum in 37%, and purulent secretion in 1%. While no findings were observed in 19% of the patients during bronchoscopy and no procedure was performed, 55% received topical applications, 7% received only thermal applications, and 19% received both thermal and endobronchial treatments (EBT). Conclusion: We believe that our study will support the existing literature by revealing that bronchoscopy plays an important role in the diagnosis and treatment processes of patients with haemoptysis and that this method has the potential to increase its clinical contributions in the future.
- Open Access
- 1 April 2025
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 33 (2) , 217-225
The efficacy of topical mitomycin-C in the treatment of benign tracheal stenosis: A comparative study
Background: This study aims to examine the efficacy of mitomycin-C (MMC) in patients with benign tracheal stenosis who have re-stenosis requiring repeated interventional bronchoscopy. Methods: Between January 2009 and December 2019, a total of 25 patients who underwent repeated procedures for re-stenosis were retrospectively analyzed. The study group consisted of 11 patients (7 males, 4 females; median age: 37 years; range, 16 to 63 years) who underwent MMC following routine dilation and the control group consisted of 14 patients (8 males, 6 females; median age: 52 years; range, 19 to 73 years) who underwent dilation alone and did not receive MMC. Demographic data of the patients, the etiology of stenosis, comorbidities, medications used, imaging studies, location, degree and length of re-stenosis, details of interventional bronchoscopy, pre- and post-procedural time intervals between mechanical dilation, and cost were reviewed. Results: The percentage changes of re-stenosis and mean re-stenotic segment length significantly decreased (p=0.013 and p=0.029, respectively), and the medical cost (p=0.021), and number of repeated dilations (p=0.020) were lower in the MMC-treated group, compared to the control group. However, the improvement rate was not significantly different (p=0.070) between the MMC-treated group and control group. Conclusion: Mitomycin-C is helpful to decrease the tracheal re-stenosis percentage changes and the number of repeated dilations in patients with benign tracheal stenosis. It also decreases the median re-stenotic segment lengths which may be crucial for limited reserve surgery in tracheal resections. Taken together, MMC is a cost-effective, time-saving and tracheal-sparing treatment in patients with benign tracheal stenosis.
- 1 April 2025
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 33 (2) , 217-225
Open AccessThe efficacy of topical mitomycin-C in the treatment of benign tracheal stenosis: A comparative study
Background: This study aims to examine the efficacy of mitomycin-C (MMC) in patients with benign tracheal stenosis who have re-stenosis requiring repeated interventional bronchoscopy. Methods: Between January 2009 and December 2019, a total of 25 patients who underwent repeated procedures for re-stenosis were retrospectively analyzed. The study group consisted of 11 patients (7 males, 4 females; median age: 37 years; range, 16 to 63 years) who underwent MMC following routine dilation and the control group consisted of 14 patients (8 males, 6 females; median age: 52 years; range, 19 to 73 years) who underwent dilation alone and did not receive MMC. Demographic data of the patients, the etiology of stenosis, comorbidities, medications used, imaging studies, location, degree and length of re-stenosis, details of interventional bronchoscopy, pre- and post-procedural time intervals between mechanical dilation, and cost were reviewed. Results: The percentage changes of re-stenosis and mean re-stenotic segment length significantly decreased (p=0.013 and p=0.029, respectively), and the medical cost (p=0.021), and number of repeated dilations (p=0.020) were lower in the MMC-treated group, compared to the control group. However, the improvement rate was not significantly different (p=0.070) between the MMC-treated group and control group. Conclusion: Mitomycin-C is helpful to decrease the tracheal re-stenosis percentage changes and the number of repeated dilations in patients with benign tracheal stenosis. It also decreases the median re-stenotic segment lengths which may be crucial for limited reserve surgery in tracheal resections. Taken together, MMC is a cost-effective, time-saving and tracheal-sparing treatment in patients with benign tracheal stenosis.
- Open Access
- 8 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (45) , e40535
A descriptive analysis of 21 patients with pulmonary amyloidosis: An observational study
Pulmonary amyloidosis is an extremely rare disease, often detected incidentally because of its asymptomatic nature and potential to result in fatal outcomes. In this study, we aimed to present the clinical and radiological features of patients diagnosed with pulmonary amyloidosis by biopsy. This descriptive study included 21 patients with pathologically diagnosed pulmonary amyloidosis. Pulmonary amyloidosis was classified as diffuse alveolar-septal amyloidosis (DASA), cystic amyloidosis (CPA), tracheobronchial amyloidosis (TBA), nodular amyloidosis (NPA), and extraparenchymal pulmonary amyloidosis (pleural and mediastinal lymph node). Clinical, bronchoscopic, and radiological specific characteristics were presented in detail to be used for differential diagnosis. The median age of the patients was 63 (40–83) years, and 14 (66.7%) were male. Twenty patients (95.2%) presented with at least 1 comorbidity. All patients diagnosed with tracheobronchial amyloidosis were symptomatic at presentation, whereas those diagnosed with NPA/extraparenchymal amyloidosis were often asymptomatic. The patients included 1 case of DASA, 1 case of CPA, 10 cases of NPA, 6 cases of TBA, and 3 cases of extraparenchymal amyloidosis involving the mediastinal lymph node and pleura. Sixteen patients (76.2%) were classified as localized amyloidosis, while 5 patients (23.8%) were classified as systemic amyloidosis following the diagnosis of multiple myeloma, monoclonal gammopathy of undetermined significance, systemic lupus erythematosus, Sjogren’s syndrome, and B-cell lymphoma. Bronchoscopic biopsies were sufficient for diagnosis, and notably, even transbronchial needle aspiration could be a useful diagnostic method. During the follow-up, we observed that the disease remained stable without progression. However, it is important to note that patients with concurrent malignancies experience fatal outcomes. In conclusion, it is crucial to distinguish pulmonary amyloidosis from other pulmonary diseases such as malignancies, infectious diseases, and interstitial lung diseases, which may have similar clinical and radiological findings. Bronchoscopic diagnostic methods are usually sufficient for the diagnosis. Although patients with pulmonary involvement mostly remain stable during long-term follow-up without progression, it is important to consider the risk of malignancy.
- 8 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (45) , e40535
Open AccessA descriptive analysis of 21 patients with pulmonary amyloidosis: An observational study
Pulmonary amyloidosis is an extremely rare disease, often detected incidentally because of its asymptomatic nature and potential to result in fatal outcomes. In this study, we aimed to present the clinical and radiological features of patients diagnosed with pulmonary amyloidosis by biopsy. This descriptive study included 21 patients with pathologically diagnosed pulmonary amyloidosis. Pulmonary amyloidosis was classified as diffuse alveolar-septal amyloidosis (DASA), cystic amyloidosis (CPA), tracheobronchial amyloidosis (TBA), nodular amyloidosis (NPA), and extraparenchymal pulmonary amyloidosis (pleural and mediastinal lymph node). Clinical, bronchoscopic, and radiological specific characteristics were presented in detail to be used for differential diagnosis. The median age of the patients was 63 (40–83) years, and 14 (66.7%) were male. Twenty patients (95.2%) presented with at least 1 comorbidity. All patients diagnosed with tracheobronchial amyloidosis were symptomatic at presentation, whereas those diagnosed with NPA/extraparenchymal amyloidosis were often asymptomatic. The patients included 1 case of DASA, 1 case of CPA, 10 cases of NPA, 6 cases of TBA, and 3 cases of extraparenchymal amyloidosis involving the mediastinal lymph node and pleura. Sixteen patients (76.2%) were classified as localized amyloidosis, while 5 patients (23.8%) were classified as systemic amyloidosis following the diagnosis of multiple myeloma, monoclonal gammopathy of undetermined significance, systemic lupus erythematosus, Sjogren’s syndrome, and B-cell lymphoma. Bronchoscopic biopsies were sufficient for diagnosis, and notably, even transbronchial needle aspiration could be a useful diagnostic method. During the follow-up, we observed that the disease remained stable without progression. However, it is important to note that patients with concurrent malignancies experience fatal outcomes. In conclusion, it is crucial to distinguish pulmonary amyloidosis from other pulmonary diseases such as malignancies, infectious diseases, and interstitial lung diseases, which may have similar clinical and radiological findings. Bronchoscopic diagnostic methods are usually sufficient for the diagnosis. Although patients with pulmonary involvement mostly remain stable during long-term follow-up without progression, it is important to consider the risk of malignancy.
- Open Access
- 23 August 2024
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 54 (4) , 615-622
Management of airway complications following lung transplantation: first interventional bronchoscopy experience in Türkiye
Background/Aim:Lung transplantation is the treatment of last resort for many chronic lung diseases. Airway complications (AC) following lung transplantation such as bronchial stenosis, dehiscence, malacia, and fistula account for frequent hospital admissions, additional treatment costs, decreased quality of life and survival. Beyond surgical and medical preventive efforts, interventional bronchoscopy (IB) can be used in the management of these complications.The aim of the study is to evaluate the efficacy of IB on the management of AC following lung transplantation.Material and Methods: The data of lung transplant patients with AC who were referred to our interventional pulmonology unit between December 2012 and December 2019 were retrospectively analyzed.Results: Among a total of 116 lung transplants the data of 14/116 (12%) patients and 14/220 (6.3%) anastomoses in the same lung transplant group with AC requiring IB were analysed. In these 14 patients diseases leading to lung transplantation were interstitial lung diseases (ILD) (50.0%), bronchiectasis (28.6%), pulmonary arterial hypertension (PAH) (7.1%), chronic obstructive pulmonary disease (COPD) (7.1%) and COPD + bronchiectasis (7.1%). Airway stenosis was the most common airway complication, and developed mostly on the right bronchial system.Twenty-seven sessions of IB were performed on 14 patients with an average 2-3 IB per patient. Airway patency was successfully achieved in 74.1% of the procedures. Mechanical dilatation with balloon and/or rigid tube was the most preferred procedure (81.5%). Permanent airway patency was achieved in 8 (57.4%) patients. No early complications were encountered (0%). The late complication rate was 48.1%. The most frequent late complication was restenosis, which cannot be directly attributed to IB.Conclusion: IB performed on lung transplant patients with AC are safe with low procedural complication rates and can be performed repeatedly. Because of the high rate of restenosis interventional pulmonologists need better treatment modalities with lower rates of restenosis.
- 23 August 2024
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 54 (4) , 615-622
Open AccessManagement of airway complications following lung transplantation: first interventional bronchoscopy experience in Türkiye
Background/Aim:Lung transplantation is the treatment of last resort for many chronic lung diseases. Airway complications (AC) following lung transplantation such as bronchial stenosis, dehiscence, malacia, and fistula account for frequent hospital admissions, additional treatment costs, decreased quality of life and survival. Beyond surgical and medical preventive efforts, interventional bronchoscopy (IB) can be used in the management of these complications.The aim of the study is to evaluate the efficacy of IB on the management of AC following lung transplantation.Material and Methods: The data of lung transplant patients with AC who were referred to our interventional pulmonology unit between December 2012 and December 2019 were retrospectively analyzed.Results: Among a total of 116 lung transplants the data of 14/116 (12%) patients and 14/220 (6.3%) anastomoses in the same lung transplant group with AC requiring IB were analysed. In these 14 patients diseases leading to lung transplantation were interstitial lung diseases (ILD) (50.0%), bronchiectasis (28.6%), pulmonary arterial hypertension (PAH) (7.1%), chronic obstructive pulmonary disease (COPD) (7.1%) and COPD + bronchiectasis (7.1%). Airway stenosis was the most common airway complication, and developed mostly on the right bronchial system.Twenty-seven sessions of IB were performed on 14 patients with an average 2-3 IB per patient. Airway patency was successfully achieved in 74.1% of the procedures. Mechanical dilatation with balloon and/or rigid tube was the most preferred procedure (81.5%). Permanent airway patency was achieved in 8 (57.4%) patients. No early complications were encountered (0%). The late complication rate was 48.1%. The most frequent late complication was restenosis, which cannot be directly attributed to IB.Conclusion: IB performed on lung transplant patients with AC are safe with low procedural complication rates and can be performed repeatedly. Because of the high rate of restenosis interventional pulmonologists need better treatment modalities with lower rates of restenosis.
- 6 October 2023
- Published by Galenos Yayinevi in Hamidiye Medical Journal
- Vol. 4 (1) , 22-27
The Diagnostic Value of Procalcitonin in Differentiation of Exacerbation and Pneumonia in Patients with Idiopathic Pulmonary Fibrosis
- 6 October 2023
- Published by Galenos Yayinevi in Hamidiye Medical Journal
- Vol. 4 (1) , 22-27
The Diagnostic Value of Procalcitonin in Differentiation of Exacerbation and Pneumonia in Patients with Idiopathic Pulmonary Fibrosis
- Open Access
- 22 September 2023
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 308-311
A rare case: Endobronchial solitary mixed papilloma
Endobronchial solitary papillomas are extremely rare lung neoplasms origi-nating from the bronchial surface epithelium. They often present with cough or recurrent hemoptysis. These tumors are benign, but they should be fol-lowed closely because they may even have a low probability of malignant transformation features. It should be kept in mind that malignancy may devel-op especially if the patient is a smoker. Although the etiology is not known for certain, it is thought to be caused by human papillomavirus in some cases. A 43-year-old male patient was admitted with a complaint of chronic cough. Rigid bronchoscopy was performed for diagnostic and therapeutic purposes after imaging techniques revealed a lesion obstructing the lumen of the right main bronchus. The pathology result was reported as mixed bronchial papil-loma. We aimed to present our case because of its rarity and to indicate that chronic cough must be further evaluated.
- 22 September 2023
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 71 (3) , 308-311
Open AccessA rare case: Endobronchial solitary mixed papilloma
Endobronchial solitary papillomas are extremely rare lung neoplasms origi-nating from the bronchial surface epithelium. They often present with cough or recurrent hemoptysis. These tumors are benign, but they should be fol-lowed closely because they may even have a low probability of malignant transformation features. It should be kept in mind that malignancy may devel-op especially if the patient is a smoker. Although the etiology is not known for certain, it is thought to be caused by human papillomavirus in some cases. A 43-year-old male patient was admitted with a complaint of chronic cough. Rigid bronchoscopy was performed for diagnostic and therapeutic purposes after imaging techniques revealed a lesion obstructing the lumen of the right main bronchus. The pathology result was reported as mixed bronchial papil-loma. We aimed to present our case because of its rarity and to indicate that chronic cough must be further evaluated.
- 14 April 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (1) , 6-11
Comparison of Radiological Imaging and Reverse Transcriptase Polymerase Chain Reaction Test in Preoperative Screening for Detection of COVID-19
- 14 April 2022
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 7 (1) , 6-11
Comparison of Radiological Imaging and Reverse Transcriptase Polymerase Chain Reaction Test in Preoperative Screening for Detection of COVID-19
- Open Access
- 1 July 2021
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 29 (3) , 360-369
Secondary pulmonary malignancies requiring interventional bronchoscopic procedures
Background: In this study, we aimed to share our singlecenter experience and to investigate the effect of interventional bronchoscopic procedures on secondary pulmonary malignancies in terms of complications, success, and survival rates. Methods: A total of 83 patients (42 males, 41 females; mean age: 57.8±15.2 years; range, 18 to 94 years) with secondary pulmonary malignancies who underwent interventional bronchoscopic procedures between January 2009 and December 2019 were retrospectively reviewed. Data including demographic and clinical characteristics of the patients, complications, and success and survival rates were recorded. Results: The most common secondary pulmonary malignancies were kidney and thyroid tumors with the complaints of cough, shortness of breath, and hemoptysis. The mean duration before the diagnosis was 34.7±52.8 (range, 0.1 to 219.3) months, and the mean survival after the diagnosis were 10±13.1 (range, 0.2 to 44.4) months. A total of 92% of the patients had an airway obstruction of >50% and the interventional bronchoscopic procedures such as argon plasma coagulation, laser, cryo, and mechanical resection were successful in achieving airway patency. Laser application was found to significantly improve survival (p=0.015). Acute complication rate was 8.4% and mortality rate was 0%. Conclusion: In patients with tracheobronchial lesions due to secondary pulmonary malignancies, interventional bronchoscopic procedures, regardless of the stage of the disease, provide rapid palliation in life-threatening symptoms such as dyspnea and hemoptysis due to airway obstruction, prolonging patient"s survival and gain time for additional treatments to take effect for primary disease.
- 1 July 2021
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 29 (3) , 360-369
Open AccessSecondary pulmonary malignancies requiring interventional bronchoscopic procedures
Background: In this study, we aimed to share our singlecenter experience and to investigate the effect of interventional bronchoscopic procedures on secondary pulmonary malignancies in terms of complications, success, and survival rates. Methods: A total of 83 patients (42 males, 41 females; mean age: 57.8±15.2 years; range, 18 to 94 years) with secondary pulmonary malignancies who underwent interventional bronchoscopic procedures between January 2009 and December 2019 were retrospectively reviewed. Data including demographic and clinical characteristics of the patients, complications, and success and survival rates were recorded. Results: The most common secondary pulmonary malignancies were kidney and thyroid tumors with the complaints of cough, shortness of breath, and hemoptysis. The mean duration before the diagnosis was 34.7±52.8 (range, 0.1 to 219.3) months, and the mean survival after the diagnosis were 10±13.1 (range, 0.2 to 44.4) months. A total of 92% of the patients had an airway obstruction of >50% and the interventional bronchoscopic procedures such as argon plasma coagulation, laser, cryo, and mechanical resection were successful in achieving airway patency. Laser application was found to significantly improve survival (p=0.015). Acute complication rate was 8.4% and mortality rate was 0%. Conclusion: In patients with tracheobronchial lesions due to secondary pulmonary malignancies, interventional bronchoscopic procedures, regardless of the stage of the disease, provide rapid palliation in life-threatening symptoms such as dyspnea and hemoptysis due to airway obstruction, prolonging patient"s survival and gain time for additional treatments to take effect for primary disease.